Developing Medical Innovation

We develop new technologies from the NHS and beyond to improve patient care

Realising Potential

Medovate is a dynamic medical device company dedicated to the development and commercialisation of innovative medical technologies created within the NHS.

Medovate provides technical, management and financial support to develop medical devices through clinical trials, regulatory approval and market launch, in order to improve patient safety and healthcare delivery.

Our current pipeline of novel medical technologies is focussed on anaesthesia, airway, critical care and surgery.

Read More

Latest News

Keep up to date with Medovate News & Events


Medovate unveils US launch plans for regional anaesthesia innovation

4th February, 2020

Medovate is breaking into the US market with the launch of the FDA approved SAFIRA regional anaesthesia innovation, at ASRA 2020 (the 45th Annual Regional Anesthesiology and Acute Pain Medicine Meeting), taking place in San Francisco on the 23rd - 25th April. In addition to this, Medovate has also joined the Association of British Healthcare Industries (ABHI) US Accelerator.


Medovate continues growth with significant office expansion

29th November, 2019

Exactly two years since launch, Medovate, the medical device development company, is excited to be moving into its next chapter of growth with a relocation that will increase its capacity dramatically.


Medovate appoints new Sales and Marketing Director to showcase medtech innovations

11th October, 2019

Medovate, the medical device development company, is pleased to announce the appointment of Chris Rogers as its new Sales and Marketing Director.